Marie P.
- Country
- France
- Department
- Infectious disease
Research Overview
- A Phase 3 Open-label Clinical Study of Doravirine/Islatravir (DOR/ISL [100 mg/0.25 mg]) Once Daily for the Treatment of HIV-1 Infection in Participants Who Previously Received DOR/ISL (100 mg/0.75 mg) QD in a Phase 3 Clinical Study
- A Phase 3, Randomized, Active-Controlled, Open-Label Clinical Study to Evaluate a Switch to Doravirine/Islatravir (DOR/ISL 100 mg/0.25 mg) Once-Daily in Participants With HIV-1 Who Are Virologically Suppressed on Antiretroviral Therapy
Data & Insights
Has run more than one trial at 16 of 55 partner sites.
Specializations
HIV Treatment Research
This clinical investigator specializes in the study of HIV-1 infection treatment approaches, with particular focus on evaluating novel antiretroviral therapy combinations. Their research encompasses the assessment of treatment-switching strategies in patients with controlled HIV infection.
- Antiretroviral Therapy Optimization
- Long-term HIV Management
- Treatment Switch Protocols
Their work contributes to understanding the effectiveness of innovative therapeutic combinations in HIV treatment.
Clinical Safety Assessment
The investigator conducts comprehensive evaluation of safety and tolerability profiles in antiretroviral medications. Their research extends to long-term safety monitoring of HIV treatments, with studies spanning up to 96 weeks of observation.
- Drug Safety Evaluation
- Extended Duration Monitoring
- Therapeutic Tolerability Assessment
Their research emphasizes the importance of sustained safety assessment in HIV treatment protocols.
Viral Suppression Studies
The investigator focuses on researching antiretroviral efficacy through measurement of HIV-1 RNA levels. Their work includes evaluation of viral suppression maintenance in patients transitioning between different treatment regimens.
- Viral Load Monitoring
- Treatment Efficacy Assessment
- Therapeutic Response Evaluation
Their research aims to establish the effectiveness of new treatment combinations in maintaining viral suppression.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.